Improvement of physical stability and dissolution rate of celecoxib suspensions by complexation with β-cyclodextrins

Pharmazie

Volumn 59, Issue 8, 2004, Pages 627-630

  Rao, G Chandra Sekhara ^a,b   Kumar, M Satish ^a   Mathivanan, N ^a   Rao, M E Bhanoji ^a  

^a ROLAND INSTITUTE OF PHARMACEUTICAL SCIENCES   (India)

^b Roland Inst of Pharmaceutical Sci   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CYCLODEXTRIN; CARBOXYMETHYLCELLULOSE; CELECOXIB;

ARTICLE; COMPLEX FORMATION; DIFFERENTIAL SCANNING CALORIMETRY; DISPERSION; DRUG FORMULATION; DRUG SOLUBILITY; DRUG STABILITY; FREEZING; PARTICLE SIZE; REDISPERSIBILITY; SEDIMENTATION; SOLID; SOLID DISPERSION; STOICHIOMETRY; SUSPENSION; THAWING; VISCOSITY;

CALORIMETRY, DIFFERENTIAL SCANNING; CENTRIFUGATION; CYCLODEXTRINS; CYCLOOXYGENASE INHIBITORS; DRUG STABILITY; EXCIPIENTS; FREEZING; KINETICS; PARTICLE SIZE; PYRAZOLES; SOLUBILITY; SULFONAMIDES; SUSPENSIONS; VISCOSITY;

EID: 4143049080     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. st ed., Mack Publishing Company, Pennsylvania, p. 173-188.
2. Amidon GL, Lennernäs H, Shah VP, Crison JR (1995) A theoretical basis for a biopharmaceutic drug classification: The correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res 12: 413-420.
3. th ed., Merck & Co., Inc., White House Station, NJ, p. 336.
4. Cwiertnia B, Hladon T, Stobiecki M (1999) Stability of diclofenac sodium in the inclusion complex with β-cyclodextrin in the solid state. J Pharm Pharmacol 51: 1213-1218.
5. Hees TV, Piel G, Hassonville SHD, Evrard B, Delattre L (2002) Determination of the free/included piroxicam ratio in cyclodextrin complexes: comparison between UV spectrophotometry and differential scanning calorimetry. Eur J Pharm Sci 15: 347-353.
6. Jain NK, Mishra PR, Mamta mishra, Namdeo A (1999) Pharmaceutical potential of cyclodextrins. Indian J Pharm Sci 61: 193-198.
7. Khan KA (1975) The concept of dissolution efficiency. J Pharm Pharmacol 27: 48-49.
8. Meyer RJ, Cohen L (1959) Rheology of natural and synthetic hydrophilic polymer solutions and related to suspending ability. J Soc Cosmet Chem 10: 1-11.
9. Michaels AS, Bolger (1962) The plastic flow behaviour of flocculated Kaolin suspension. Ind Eng Chem Fundam 1: 153-162.
10. Mitchell SA, Reynolds TD, Dusbach TP (2003) A compaction process to enhance dissolution of poorly water soluble drugs using hydroxypropylmethylcellulose. Int J Pharm 250: 3-11.
11. Nash RA (1996) Pharmaceutical suspensions. In: Liberman HA, Rieger MA, Banker GS (ed.) Pharmaceutical dosage forms Disperse systems, 2nd ed., vol. 2, Marcel Dekker, New York, p. 1-46.
12. Rajewski RA, Stella VJ (1996) Pharmaceutical applications of cyclodextrins. 2. In vivo drug delivery. J Pharm. Sci 85: 1142-1169.
13. nd ed., Marcel Dekker Inc., New York, p. 327-354.
14. Samyn JC (1961) An industrial approach to suspension formulation. J Pharm. Sci 50: 517-522.
15. Sankar DG, Reddy MN, Murthy TK (2001) UV spectrophotometric methods for the determination of celecoxib and tizanidine hydrochloride. Indian J Pharm Sci 63: 521-523.
16. nd ed., Churchill Livingston Ltd., London, p. 152-165.
17. th ed., J. B. Lippincott company, Philadelphia, p. 175-232.
18. th ed., vol. 1, Lippincott Williams and Wilkins, Philadelphia, p. 316-334.
19. Szejtli J (1994) Medicinal applications of cyclodextrins. Med Res Rev 14: 353-386.